Device and Methods for Subcutaneous Delivery of High Viscosity Fluids

• US 20100130958A1
• Filed: 11/26/2008
• Published: 05/27/2010
• Est. Priority Date: 11/26/2008
• Status: Abandoned Application

• Current Assignee: Halozyme, Inc. (Halozyme Therapeutics, Inc.)
• Original Assignee: Halozyme, Inc. (Halozyme Therapeutics, Inc.)
• Inventors: Kang, David, Zepeda, Monica
• Application Number:
  US12/324,562
• Publication Number:
  US 20100130958A1
• Time in Patent Office: Days
• US Class Current: 604/506
• CPC Class Codes: A61M 2005/1581 Right-angle needle-type devices
• CPC Class Codes: A61M 2202/0468 non-physiological
• CPC Class Codes: A61M 5/1452 pressurised by means of pistons
• CPC Class Codes: A61M 5/158 Needles for infusions; Accessories therefor, e.g. for inserting infusion needles, or for holding them on the body

Abstract

The present invention provides infusion devices and methods for subcutaneous delivery of high viscosity fluids. The devices and methods described are innovative subcutaneous infusion systems that allow for the rapid delivery of viscous therapeutic fluids while avoiding adverse side effects and promoting patient comfort. The devices and methods described are also useful for rapid delivery of high volumes of therapeutic fluids.

Claims

1. A subcutaneous infusion system comprising:

a) a needle of 24 to 27 Ga comprising a shaft having an internal duct of unvarying diameter defining a fluid pathway between openings at distal and proximal ends of the needle, and wherein a hub in fluid communication with the duct is disposed at the distal end and the needle length therefrom to the proximal end is about 4 to 6 mm; and

b) a medication dispensing device in detachable fluid communication with the needle duct, the device containing about 3 to 100 mls of a highly viscous therapeutic fluid composition, wherein the system is configured for subcutaneous delivery of the therapeutic fluid composition at a flow rate of about 1-20 mls per minute.

2. The infusion system of claim 1, wherein the dispensing device is attachable to the hub for indirect fluid communication with the needle duct.

3. The infusion system of claim 1, wherein the needle and delivery device are in fluid communication via tubing connecting the distal opening of the needle to the dispensing device.

4. The infusion system of claim 3, wherein the tubing has an internal diameter of about 1-1.2 mm.

5. The infusion system of claim 4, wherein the tubing has an internal diameter of about 1 mm.

6. The infusion system of claim 3, wherein the tubing has a length of about 6 to 10 inches.

7. The infusion system of claim 1, wherein the needle is straight.

8. The infusion system of claim 1, wherein the needle has a bent shaft.

9. The infusion system of claim 8, wherein the shaft is bent 90 degrees.

10. The infusion system of claim 1, wherein the delivery device includes about 3 to 15 mls of a therapeutic fluid composition.

11. The infusion system of claim 10, wherein the delivery device includes about 10 to 15 mls of a therapeutic fluid composition.

12. The infusion system of claim 1, wherein the therapeutic fluid composition has a viscosity of about 10 to 20 cP.

13. The infusion system of claim 1, wherein the dispensing device comprises a fluid reservoir.

14. The infusion system of claim 13, wherein the dispensing device is a syringe.

15. The infusion system of claim 14, wherein the syringe is automated for constant fluid delivery.

16. The infusion system of claim 13, wherein the fluid reservoir is a pre-filled cartridge.

17. The infusion system of claim 16, wherein the fluid reservoir is pressurized.

18. The infusion system of claim 1, wherein the needle comprises any number greater than 1 opening or hole disposed on the side of each needle shaft up to as many as can be added without impairing rigidity or structural integrity of the needle shaft.

19. The infusion system of claim 1, wherein the system further comprises additional needles of 24 to 27 Ga, wherein each additional needle comprises a second shaft having an internal duct of unvarying diameter defining a fluid pathway between openings at distal and proximal ends of each needle;

and further wherein the hub is also in fluid communication with at least one additional needle and each additional needle has a length of about 4 to 6 mm measured from the hub to the proximal opening of the second needle.

20. The infusion system of claim 19, wherein the first and additional needles are the same gauge.

21. The infusion system of claim 19, wherein each needle comprises any number greater than 1 opening or hole disposed on the side of each needle shaft up to as many as can be added without impairing rigidity or structural integrity of the needle shaft.

22. The infusion system of claim 19, wherein the system comprises one additional needle.

23. The infusion system of claim 1, wherein the system is configured for subcutaneous delivery of the therapeutic fluid composition at a flow rate of about 3-5 ml/min.

24. A method for subcutaneous delivery of a high viscosity therapeutic fluid composition to a subject in need thereof comprising administering to the subject a therapeutic fluid using the device of claim 1, wherein the therapeutic fluid is administered at a flow rate of about 1-20 ml/min.

25. The method of claim 24, wherein the therapeutic fluid is administered at a flow rate of about 3-5 ml/min.

26. The method of claim 24, wherein the therapeutic fluid has a viscosity of about 10 to 20 cP.

27. The method of claim 24, wherein the flow rate is greater than about 10 ml/min and the therapeutic fluid has a viscosity less than about 5 cP.

28. The method of claim 24, wherein the therapeutic fluid is administered through the dermis of the abdomen, arm or thigh.

29. The method of claim 24, wherein the therapeutic fluid comprises a hyaluronidase enzyme.

30. The method of claim 29, wherein the therapeutic fluid comprises a hyaluronidase is a human hyaluronidase.

31. The method of claim 30, wherein the therapeutic fluid comprises a chemotherapeutic agent.

32. A method for subcutaneous delivery of a high volume of a therapeutic fluid to a subject in need thereof comprising administering to the subject a therapeutic fluid using a subcutaneous infusion system comprising:

a) a needle of 18 Ga comprising a shaft having an internal duct of unvarying diameter defining a fluid pathway between openings at distal and proximal ends of the needle, and wherein a hub in fluid communication with the duct is disposed at the distal end and the needle length therefrom to the proximal end is about 4 to 6 mm; and

b) a medication dispensing device in detachable fluid communication with the needle duct, the device containing about 3 to 100 mls of a highly viscous therapeutic fluid composition,

wherein the fluid is administered at a flow rate greater than about 20 ml/min.

33. The infusion system of claim 32, wherein the needle comprises any number greater than 1 opening or hole disposed on the side of each needle shaft up to as many as can be added without impairing rigidity or structural integrity of the needle shaft.

34. The method of claim 32, wherein the system further comprises additional needles, wherein each additional needle comprises a second shaft having an internal duct of unvarying diameter defining a fluid pathway between openings at distal and proximal ends of each needle;

and further wherein the hub is also in fluid communication with at least one additional needle and each additional needle has a length of about 4 to 6 mm measured from the hub to the proximal opening of the second needle.

35. The infusion system of claim 34, wherein each needle comprises any number greater than 1 opening or hole disposed on the side of each needle shaft up to as many as can be added without impairing rigidity or structural integrity of the needle shaft.